The expression level of HSD17B12 correlated with the severity of ovarian cancer, and its expression mimicked COX-2 expression, indicating its role in increased arachidonic acid and PGE2 production during ovarian cancer progression (Kemiläinen et al. 2018). The gene discussed is PTGS2; the disease is ovarian carcinoma.